CBU
TXG icon

CIBC Bancorp USA’s 10x Genomics TXG Stock Holding History

CIBC Bancorp USA’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$252K Buy
+6,583
New +$173K ﹤0.01% 1648
2025
Q3 		$134K Buy
+11,434
New +$149K ﹤0.01% 1324

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

CIBC Bancorp USA's TXG Position: Q2 2026 in Review

CIBC Bancorp USA opened a new position in 10x Genomics (TXG) in Q2 2026: 6,583 shares worth $252K. The stake represents ﹤0.01% of the portfolio and ranks #1648 among its holdings. This is a return to the name: CIBC Bancorp USA previously reported a position in TXG as recently as Q3 2025.

CIBC Bancorp USA first reported a position in TXG in Q3 2025 and has held it in 2 quarters since. 393 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • CIBC Bancorp USA held 6,583 shares of 10x Genomics worth $252K as of Q2 2026.
  • 10x Genomics was a new CIBC Bancorp USA position in Q2 2026.
  • 10x Genomics made up ﹤0.01% of CIBC Bancorp USA's portfolio in Q2 2026, its #1648 holding.
  • CIBC Bancorp USA first reported a position in 10x Genomics in Q3 2025 and has held it in 2 quarters since.
  • 393 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on CIBC Bancorp USA's 13F filing for Q2 2026, filed 13 Aug 2026.